Alnylam Pharmaceuticals, Inc.Alnylam Pharmaceuticals, Inc.Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

No trades
See on Supercharts
Market capitalization
‪18.70 B‬USD
−3.53USD
‪−440.24 M‬USD
‪1.83 B‬USD
‪125.26 M‬
Beta (1Y)
1.34

About Alnylam Pharmaceuticals, Inc.

CEO
Yvonne L. Greenstreet
Headquarters
Cambridge
Employees (FY)
‪2.1 K‬
Founded
2002
ISIN
US02043Q1076
FIGI
BBG000BFGNJ5
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. The company was founded by Noble Laureate, David Bartel, Thomas Tuschl, Phillip Zamore, Paul R. Schimmel, and Phillip Allen Sharp on June 14, 2002 and is headquartered in Cambridge, MA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where ALNY is featured.

Frequently Asked Questions

The current price of ALNY is 147.70 USD — it has decreased by 0.54% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Alnylam Pharmaceuticals, Inc. stocks are traded under the ticker ALNY.
Alnylam Pharmaceuticals, Inc. is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Alnylam Pharmaceuticals, Inc. has a max estimate of 395.00 USD and a min estimate of 136.00 USD.
ALNY earnings for the last quarter are 1.15 USD whereas the estimation was −1.45 USD which accounts for 179.55% surprise. Estimated earnings for the next quarter are −1.19 USD. See more details about Alnylam Pharmaceuticals, Inc. earnings.
Alnylam Pharmaceuticals, Inc. revenue for the last quarter amounts to ‪750.53 M‬ USD despite the estimated figure of ‪396.76 M‬ USD. In the next quarter revenue is expected to reach ‪436.92 M‬ USD.
Yes, you can track Alnylam Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, ALNY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Alnylam Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
ALNY reached its all-time high on Dec 21, 2022 with the price of 242.97 USD, and its all-time low was 3.65 USD and was reached on Aug 18, 2004.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has ‪2.10 K‬ employees. See our rating of the largest employees — is Alnylam Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Alnylam Pharmaceuticals, Inc. EBITDA is ‪−228.12 M‬ USD, and current EBITDA margin is −12.48%. See more stats in Alnylam Pharmaceuticals, Inc. financial statements.